LOVASTATIN Drug Patent Profile
✉ Email this page to a colleague
When do Lovastatin patents expire, and when can generic versions of Lovastatin launch?
Lovastatin is a drug marketed by Actavis Elizabeth, Aurobindo Pharma Usa, Carlsbad, Chartwell Rx, Corepharma, Epic Pharma Llc, Lupin, Sun Pharm Industries, and Teva. and is included in ten NDAs.
The generic ingredient in LOVASTATIN is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lovastatin
A generic version of LOVASTATIN was approved as lovastatin by ACTAVIS ELIZABETH on December 17th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOVASTATIN?
- What are the global sales for LOVASTATIN?
- What is Average Wholesale Price for LOVASTATIN?
Summary for LOVASTATIN
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 22 |
| Raw Ingredient (Bulk) Api Vendors: | 124 |
| Clinical Trials: | 76 |
| Drug Prices: | Drug price information for LOVASTATIN |
| Drug Sales Revenues: | Drug sales revenues for LOVASTATIN |
| DailyMed Link: | LOVASTATIN at DailyMed |
See drug prices for LOVASTATIN
Recent Clinical Trials for LOVASTATIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assiut University | N/A |
| Heart Health Research Center | Phase 4 |
| AstraZeneca | Phase 4 |
Pharmacology for LOVASTATIN
| Drug Class | HMG-CoA Reductase Inhibitor |
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for LOVASTATIN
Anatomical Therapeutic Chemical (ATC) Classes for LOVASTATIN
US Patents and Regulatory Information for LOVASTATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | LOVASTATIN | lovastatin | TABLET;ORAL | 075551-003 | Dec 17, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | LOVASTATIN | lovastatin | TABLET;ORAL | 075551-002 | Dec 17, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Elizabeth | LOVASTATIN | lovastatin | TABLET;ORAL | 075828-001 | Dec 17, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Corepharma | LOVASTATIN | lovastatin | TABLET;ORAL | 077748-003 | Feb 28, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
